Are any of these medications associated with hyperhidrosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications Associated with Hyperhidrosis

Duloxetine (Cymbalta) is the only medication in the provided list that is associated with hyperhidrosis as a common side effect. 1

Medication Review for Hyperhidrosis Association

Confirmed Hyperhidrosis-Associated Medication

  • Duloxetine (CYMBALTA) - Hyperhidrosis is listed as one of the most common adverse reactions, occurring in approximately 6% of patients taking duloxetine compared to 1% in placebo groups 1. The FDA label specifically identifies hyperhidrosis as one of the most commonly observed adverse reactions in duloxetine-treated patients across all populations 1.

Medications with Potential Autonomic Effects but Not Specifically Associated with Hyperhidrosis

  • Spironolactone (ALDACTONE) - While it can cause various side effects, hyperhidrosis is not listed among its common adverse effects 2.
  • HydrOXYzine (ATARAX) - This medication is more commonly associated with anticholinergic effects like dry mouth rather than hyperhidrosis 2.
  • BusPIRone (BUSPAR) - Not associated with hyperhidrosis in the provided evidence 2.
  • TraZODone (DESYREL) - Not associated with hyperhidrosis in the provided evidence 2.

Medications Used to Treat Hyperhidrosis

Interestingly, some medications in the list are actually used to treat hyperhidrosis:

  • Glycopyrrolate (not in the patient's list but mentioned in guidelines) is used as a systemic treatment for hyperhidrosis 3, 4.
  • Clonidine (not in the patient's list but mentioned in guidelines) can be used for craniofacial hyperhidrosis 3, 4.

Clinical Considerations for Duloxetine-Associated Hyperhidrosis

Incidence and Presentation

  • Hyperhidrosis occurs in approximately 6% of duloxetine-treated patients versus 1% in placebo groups 1.
  • It is one of the most commonly reported adverse effects along with nausea, dry mouth, somnolence, constipation, and decreased appetite 1.
  • The sweating is typically generalized rather than focal 1.

Management Options for Medication-Induced Hyperhidrosis

If the patient is experiencing hyperhidrosis related to duloxetine:

  1. Dose adjustment - Consider lowering the dose if clinically appropriate 1.

  2. Topical treatments:

    • Aluminum chloride solutions (20-25%) as first-line treatment for focal hyperhidrosis 3, 4.
    • Glycopyrrolate topical formulations for craniofacial sweating 4.
  3. Systemic adjunctive medications if hyperhidrosis is severe but duloxetine must be continued:

    • Oral anticholinergics like glycopyrrolate (1-2 mg once or twice daily) 3, 4.
    • Clonidine (0.1 mg twice daily) may be helpful 3.
  4. Alternative antidepressant - If hyperhidrosis is intolerable, consider switching to an alternative antidepressant with lower rates of hyperhidrosis 1.

  5. Other interventions for persistent cases:

    • Iontophoresis for palmar and plantar hyperhidrosis 4, 5.
    • Botulinum toxin injections for focal hyperhidrosis 4, 6.

Monitoring and Follow-up

  • Patients should be advised that hyperhidrosis may occur as a side effect of duloxetine 1.
  • Discontinuation of duloxetine may be associated with hyperhidrosis as a withdrawal symptom 1.
  • Patients should not abruptly stop taking duloxetine without consulting their healthcare provider 1.

Conclusion

Among the medications listed in the patient's regimen, only duloxetine (Cymbalta) is associated with hyperhidrosis as a documented side effect. If the patient is experiencing troublesome sweating, this medication should be considered as the likely cause, and appropriate management strategies should be implemented.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment options for hyperhidrosis.

American journal of clinical dermatology, 2011

Research

Hyperhidrosis: Management Options.

American family physician, 2018

Research

Current therapeutic strategies for hyperhidrosis: a review.

European journal of dermatology : EJD, 2002

Research

Treatment of Hyperhidrosis: An Update.

American journal of clinical dermatology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.